Cargando…

Prevalence of Human Papillomavirus Types 16/18 and Effect of Vaccination among Japanese Female General Citizens in the Vaccine Crisis Era

The Japanese government withdrew its recommendation for human papillomavirus (HPV) vaccination in June 2013 and resumed it in April 2022. This period is known as the vaccine crisis in Japan. This study aimed to elucidate the prevalence and genotype distribution of HPV among Japanese female citizens,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitamura, Tadaichi, Suzuki, Motofumi, Shigehara, Kazuyoshi, Fukuda, Kazuko, Matsuyama, Taeko, Kume, Haruki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863140/ https://www.ncbi.nlm.nih.gov/pubmed/36680199 http://dx.doi.org/10.3390/v15010159

Ejemplares similares

Prevalence and Risk Factors of Human Papillomavirus Infection among Japanese Female People: A Nationwide Epidemiological Survey by Self-Sampling
por: Kitamura, Tadaichi, et al.
Publicado: (2021)

Prevalence, Genotype Distribution, and Predictors against HPV Infections Targeted By 2-, 4-, 9-Valent HPV Vaccines among Japanese Males
por: Matsuzawa, Yukimasa, et al.
Publicado: (2020)

Nose size indicates maximum penile length
por: Ikegaya, Hiroshi, et al.
Publicado: (2021)

The accountability of the private sector towards citizens in times of crisis: vaccines, medicines and equipment
por: Petelos, Elena, et al.
Publicado: (2021)

Significance of common variants on human chromosome 8q24 in relation to the risk of prostate cancer in native Japanese men
por: Liu, Miao, et al.
Publicado: (2009)

Human papillomavirus 16–positive penile Bowen’s disease involving the distal urethra: A case report
por: Sakamoto, Jiro, et al.
Publicado: (2020)

Perception of Japanese Physicians about Human Papillomavirus Vaccine
por: Katsuta, Tomohiro, et al.
Publicado: (2017)

Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women
por: Onuki, Mamiko, et al.
Publicado: (2022)

Risk of Increasing the Sudden Diagnosis of AIDS in Japan during and after the COVID-19 Outbreak
por: Jimba, Masamine, et al.
Publicado: (2021)

Getting Human Papillomavirus Vaccination Back on Track: Protecting Our National Investment in Human Papillomavirus Vaccination in the COVID-19 Era
por: Gilkey, Melissa B., et al.
Publicado: (2020)

Japanese physicians’ attitudes and intentions regarding human papillomavirus vaccine compared with other adolescent vaccines
por: Katsuta, Tomohiro, et al.
Publicado: (2019)

Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma
por: Kawakami, Hisato, et al.
Publicado: (2013)

A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
por: Matsushita, Hirokazu, et al.
Publicado: (2014)

Cost-effectiveness analysis of AS04-adjuvanted human papillomavirus 16/18 vaccine compared with human papillomavirus 6/11/16/18 vaccine in the Philippines, with the new 2-dose schedule
por: Germar, Maria Julieta, et al.
Publicado: (2017)

Prevalence, Potential Predictors, and Genotype-Specific Prevalence of Human Papillomavirus Infection among Sexually Active Students in Japan
por: Imai, Hirohisa, et al.
Publicado: (2015)

A favorable impression of vaccination leads to a better vaccination rate for the human papillomavirus vaccine: A Japanese questionnaire survey investigation
por: Jwa, Sinchul, et al.
Publicado: (2022)

Human papillomavirus vaccine
por: Singhal, Priyanka, et al.
Publicado: (2009)

The efficacy of human papillomavirus vaccination in young Japanese girls: the interim results of the OCEAN study
por: Hiramatsu, Kosuke, et al.
Publicado: (2021)

Immediate adverse reactions following COVID-19 vaccination among 16–65-year-old Danish citizens
por: Torp Hansen, K., et al.
Publicado: (2023)

Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
por: Zhou, Xu, et al.
Publicado: (2020)

Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
por: Vokó, Zoltán, et al.
Publicado: (2012)

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019)

Mandatory vaccinations, the segregation of citizens, and the promotion of inequality in the modern democracy of Greece and other democratic countries in the era of COVID-19
por: Mavridis, Charalampos, et al.
Publicado: (2022)

Continence Status and Presence of Pressure Skin Injury among Special Elderly Nursing Home Residents in Japan: A Nationwide Cross-Sectional Survey
por: Suzuki, Motofumi, et al.
Publicado: (2021)

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada
por: Kohli, Michele, et al.
Publicado: (2012)

Bivalent Human Papillomavirus Vaccine Effectiveness in a Japanese Population: High Vaccine-Type–Specific Effectiveness and Evidence of Cross-Protection
por: Kudo, Risa, et al.
Publicado: (2019)

Characteristics of Articles About Human Papillomavirus Vaccination in Japanese Newspapers: Time-Series Analysis Study
por: Ueda, Nao, et al.
Publicado: (2017)

A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil(®))
por: Govan, Vandana A
Publicado: (2008)

Immunogenicity and safety of the diphtheria, pertussis, tetanus and inactivated poliovirus vaccine when co-administered with the human rotavirus vaccine (Rotarix) in healthy Japanese infants: a phase IV randomized study
por: Gillard, Paul, et al.
Publicado: (2019)

Human Papillomavirus Vaccination Strategies
por: Cachafeiro, Santiago Pérez
Publicado: (2007)

Vaccination against human papillomavirus
por: Mello, Claudia Figueiredo
Publicado: (2013)

Mid-Term Results of Ab Interno Trabeculectomy among Japanese Glaucoma Patients
por: Kitamura, Kazuyoshi, et al.
Publicado: (2023)

Stability of trivalent human papillomavirus (types 16, 18, 58) recombinant vaccine (Escherichia coli)
por: Liu, Yu-Ying, et al.
Publicado: (2021)

Multiple primary malignant neoplasms of the glottis, renal pelvis, urinary bladder, oral floor, prostate, and esophagus in a Japanese male patient: a case report
por: Mukaiyama, Yoshihiro, et al.
Publicado: (2014)

Prevalence of human papillomavirus infection in the oropharynx and urine among sexually active men: a comparative study of infection by papillomavirus and other organisms, including Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma spp., and Ureaplasma spp
por: Nakashima, Kazufumi, et al.
Publicado: (2014)

Pre-vaccine era cervical human papillomavirus infection among screening population of women in west Austria
por: Borena, Wegene, et al.
Publicado: (2016)

Post-hoc analysis of injection-site reactions following vaccination with quadrivalent human papillomavirus vaccine in Japanese female clinical trial participants
por: Murata, Shinya, et al.
Publicado: (2020)

Citizens’ Initiatives for Crisis Management and the Use of Social Media: An Analysis of COVID-19 Crisis in Bangladesh
por: Baniamin, Hasan Muhammad
Publicado: (2021)

Vaccines’ New Era-RNA Vaccine
por: Zhou, Wenshuo, et al.
Publicado: (2023)

Cuba bids to vaccinate all citizens with home-grown shots
por: Taylor, Luke
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2bg6viqbimuue4e3d4jj0t6l80